Combining CAR T Cell Therapy and Oncolytic Virotherapy for Pediatric Solid Tumors: A Promising Option is a research paper published in Immuno (2023). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health (NIH)
Grant: R01CA256006
National Institutes of Health (NIH)
Grant: P50CA127001
National Institutes of Health
Grant: 3R01CA256006-04S1
NCI Diversity Supplement: Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
FWCI
1.75
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals